Insider trades
Nathan J. Dowden, COO of Entrada Therapeutics TRDA, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $425.7K. The latest trade was on 05/04.
Nathan J. Dowden
President & COO
- Company
- Entrada Therapeutics TRDA
- First filing
- 23/03/03
- Trades
- 46 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- −$425.7K
- Last trade
- 05/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/04 | 05/04 | 15,000 sh | $15.33 | $229,950 | −7.0% | |
TRDA | Open-market sale10b5-1 plan | 03/09–03/10 | 03/11 | 15,010 sh2 trades | $13.04avg. | $195,787.02 | −7.0% |
| Open-market sale10b5-1 plan | 24/09/26 | 24/09/30 | 847 sh | $16.00 | $13,552 | −0.7% | |
TRDA | Open-market sale10b5-1 plan | 24/09/06–24/09/09 | 24/09/10 | 2,303 sh2 trades | $15.09avg. | $34,754.09 | −1.8% |
TRDA | Open-market sale10b5-1 plan | 24/08/16 | 24/08/20 | 27,097 sh2 trades | $16.27avg. | $440,818.1 | −17.2% |
| Open-market sale10b5-1 plan | 24/03/06 | 24/03/08 | 1,826 sh | $12.32 | $22,496.32 | −1.3% | |
TRDA | Open-market sale10b5-1 plan | 23/09/06 | 23/09/06 | 972 sh2 trades | $13.47avg. | $13,088.18 | −2.0% |
TRDA | Open-market sale10b5-1 plan | 23/07/10–23/07/11 | 23/07/12 | 7,097 sh2 trades | $18.03avg. | $127,940.85 | −16.7% |
TRDA | Open-market sale10b5-1 plan | 23/06/20–23/06/22 | 23/06/22 | 15,982 sh2 trades | $15.42avg. | $246,435.84 | −27.3% |